Committee members disclosed the following financial or other conflicts of interest (COI) covering the period 12 months before December 2020
Member . | Employment . | Research grant . | Other research support . | Speakers’ bureau/honoraria . | Ownership interest . | Consultant/advisory board . | Other . |
---|---|---|---|---|---|---|---|
Professional Practice Committee | |||||||
Boris Draznin, MD, PhD (Chair) | University of Colorado Denver, School of Medicine | None | None | None | None | None | eDoctate (unpaid professional education) |
Vanita R. Aroda, MD | Brigham and Women’s Hospital; Faculty, Harvard Medical School | Applied Therapeutics#, Premier/Fractyl#, Novo Nordisk#, Sanofi# | None | None | Merck (spouse employee benefits), Janssen (spouse employee benefits) | Applied Therapeutics#, Duke, Novo Nordisk#*, Pfizer, Sanofi | Merck Research Laboratories (spouse employee) 2017–2020 Janssen Pharmaceutical Companies of Johnson & Johnson (spouse Sandip Datta, MD, Senior Medical Director, Early Development, Infectious Diseases, May 2020 to present) |
George Bakris, MD | University of Chicago | Bayer: principal investigator—clinical trial# | None | None | None | Merck, Relypsa/Vifor, KBP, Biosciences, Ionis, Alnylam, AstraZeneca | Steering committee member of clinical outcome trials for Vascular Dynamics and Novo Nordisk |
Gretchen Benson, RDN, LD, CDCES | Minneapolis Heart Institute Foundation | None | None | None | None | None | None |
Florence M. Brown, MD | Joslin Diabetes Center, Inc. | None | None | None | None | None | None |
RaShaye Freeman, DNP, FNP-BC, CDCES, ADM-BC | HCA Healthcare | None | None | None | None | None | None |
Jennifer Green, MD | Duke University Medical Center | Boehringer Ingelheim*#, Merck#, Sanofi Lexicon*# | None | None | None | AstraZeneca, Boehringer Ingelheim*, Novo Nordisk*, Pfizer, Hawthorne Effect | None |
Elbert Huang, MD, MPH, FACP | University of Chicago | None | None | None | Merck, Pfizer—stockholder | None | Medical Research Analytics and Informatics Alliance—BOD |
The Institute for Clinical and Economic Review—Midwest Comparative Effectiveness Public Advisory Council | |||||||
Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES | Cleveland Clinic | None | None | Abbott, Dexcom, Xeris Pharmaceuticals, Novo Nordisk, Companion Medical | None | Association of Diabetes Care and Education Specialists, Eli Lilly, Insulet, LifeScan | None |
Scott Kahan, MD, MPH | George Washington University, Milken Institute, National Center for Weight and Wellness | None | None | None | None | Vivus*, Gelesis, Pfizer | (All without compensation) |
The Obesity Society—BOD | |||||||
American Board of Obesity Medicine—BOD | |||||||
National Diabetes Education Program—author/editor | |||||||
National Academy of Science/IOM—Committee on Obesity Solutions | |||||||
Obesity Action Coalition—BOD | |||||||
Obesity Treatment Foundation—BOD | |||||||
Endocrine Society—Advocacy and Public Outreach Core Committee | |||||||
True Health Initiative—BOD | |||||||
Global Liver Institute/NASH Council—Advisory Board | |||||||
Endocrine Today—Editorial Board | |||||||
Medscape—Diabetes & Endocrinology Advisory Board | |||||||
Medscape—Obesity Advisory Board | |||||||
Strategies to Overcome and Prevent (STOP) Obesity Alliance | |||||||
Christine Lee, MD, MS | National Institute of Diabetes and Digestive and Kidney Diseases | None | None | None | None | None | None |
Jose Leon, MD, MPH | National Center for Health in Public Housing | None | None | None | None | None | None |
Sarah K. Lyons, MD | Baylor College of Medicine/Texas Children’s Hospital | None | None | None | None | None | None |
Anne L. Peters, MD | Keck School of Medicine of USC | Dexcom#, vTv Therapeutics# | None | None | Stock options | Abbott Diabetes Care, Bio-Rad, Eli Lilly, MannKind, Merck, Novo Nordisk, Zealand | Medscape Endocrinology Advisory Board/video blogger* |
Jane E.B. Reusch, MD | University of Colorado | None | None | None | None | Medtronic# | None |
Deborah Young-Hyman, PhD, CDCES | Behavioral Health & Social Science Research, National Institutes of Health | None | None | None | None | None | None |
American College of Cardiology Designated Representatives (Section 10 “Cardiovascular Disease and Risk Management”) | |||||||
Sandeep Das, MD, MPH, FACC | University of Texas Southwestern Medical Center | None | None | Associate Editor | None | None | None |
Mikhail Kosiborod, MD, FACC | Saint Luke’s Mid America Heart Institute | AstraZeneca#, Boehringer-Ingelheim# | AstraZeneca# | None | None | Amgen*, Applied Therapeutics#, AstraZeneca*#, Bayer*, Boehringer Ingelheim*, Eli Lilly, Janssen#, Merck Diabetes*, Novo Nordisk*#, Sanofi*, Vifor Pharma*# | None |
American Diabetes Association Staff | |||||||
Mindy Saraco, MHA | American Diabetes Association | None | None | None | None | None | None |
Malaika I. Hill, MA | American Diabetes Association | None | None | None | None | None | None |
Matthew P. Petersen | American Diabetes Association | None | None | None | None | None | None |
Shamera Robinson, MPH, RDN | American Diabetes Association | None | None | None | None | None | None |
Jo Mandelson, MS, RDN | American Diabetes Association | None | None | None | None | None | None |
Robert A. Gabbay, MD, PhD | American Diabetes Association (Joslin Diabetes Center) | None | None | None | None | Onduo*, Health Reveal, Form Health, Lark*, Vida Health* | Spouse Christi Gabbay, CHSE, Managing Director, Major Gifts and Philanthropy at American Diabetes Association |
Kenneth P. Moritsugu, MD, MPH | American Diabetes Association, First Samurai Consulting, LLC | None | None | None | First Samurai Consulting, LLC | None | None |
Member . | Employment . | Research grant . | Other research support . | Speakers’ bureau/honoraria . | Ownership interest . | Consultant/advisory board . | Other . |
---|---|---|---|---|---|---|---|
Professional Practice Committee | |||||||
Boris Draznin, MD, PhD (Chair) | University of Colorado Denver, School of Medicine | None | None | None | None | None | eDoctate (unpaid professional education) |
Vanita R. Aroda, MD | Brigham and Women’s Hospital; Faculty, Harvard Medical School | Applied Therapeutics#, Premier/Fractyl#, Novo Nordisk#, Sanofi# | None | None | Merck (spouse employee benefits), Janssen (spouse employee benefits) | Applied Therapeutics#, Duke, Novo Nordisk#*, Pfizer, Sanofi | Merck Research Laboratories (spouse employee) 2017–2020 Janssen Pharmaceutical Companies of Johnson & Johnson (spouse Sandip Datta, MD, Senior Medical Director, Early Development, Infectious Diseases, May 2020 to present) |
George Bakris, MD | University of Chicago | Bayer: principal investigator—clinical trial# | None | None | None | Merck, Relypsa/Vifor, KBP, Biosciences, Ionis, Alnylam, AstraZeneca | Steering committee member of clinical outcome trials for Vascular Dynamics and Novo Nordisk |
Gretchen Benson, RDN, LD, CDCES | Minneapolis Heart Institute Foundation | None | None | None | None | None | None |
Florence M. Brown, MD | Joslin Diabetes Center, Inc. | None | None | None | None | None | None |
RaShaye Freeman, DNP, FNP-BC, CDCES, ADM-BC | HCA Healthcare | None | None | None | None | None | None |
Jennifer Green, MD | Duke University Medical Center | Boehringer Ingelheim*#, Merck#, Sanofi Lexicon*# | None | None | None | AstraZeneca, Boehringer Ingelheim*, Novo Nordisk*, Pfizer, Hawthorne Effect | None |
Elbert Huang, MD, MPH, FACP | University of Chicago | None | None | None | Merck, Pfizer—stockholder | None | Medical Research Analytics and Informatics Alliance—BOD |
The Institute for Clinical and Economic Review—Midwest Comparative Effectiveness Public Advisory Council | |||||||
Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES | Cleveland Clinic | None | None | Abbott, Dexcom, Xeris Pharmaceuticals, Novo Nordisk, Companion Medical | None | Association of Diabetes Care and Education Specialists, Eli Lilly, Insulet, LifeScan | None |
Scott Kahan, MD, MPH | George Washington University, Milken Institute, National Center for Weight and Wellness | None | None | None | None | Vivus*, Gelesis, Pfizer | (All without compensation) |
The Obesity Society—BOD | |||||||
American Board of Obesity Medicine—BOD | |||||||
National Diabetes Education Program—author/editor | |||||||
National Academy of Science/IOM—Committee on Obesity Solutions | |||||||
Obesity Action Coalition—BOD | |||||||
Obesity Treatment Foundation—BOD | |||||||
Endocrine Society—Advocacy and Public Outreach Core Committee | |||||||
True Health Initiative—BOD | |||||||
Global Liver Institute/NASH Council—Advisory Board | |||||||
Endocrine Today—Editorial Board | |||||||
Medscape—Diabetes & Endocrinology Advisory Board | |||||||
Medscape—Obesity Advisory Board | |||||||
Strategies to Overcome and Prevent (STOP) Obesity Alliance | |||||||
Christine Lee, MD, MS | National Institute of Diabetes and Digestive and Kidney Diseases | None | None | None | None | None | None |
Jose Leon, MD, MPH | National Center for Health in Public Housing | None | None | None | None | None | None |
Sarah K. Lyons, MD | Baylor College of Medicine/Texas Children’s Hospital | None | None | None | None | None | None |
Anne L. Peters, MD | Keck School of Medicine of USC | Dexcom#, vTv Therapeutics# | None | None | Stock options | Abbott Diabetes Care, Bio-Rad, Eli Lilly, MannKind, Merck, Novo Nordisk, Zealand | Medscape Endocrinology Advisory Board/video blogger* |
Jane E.B. Reusch, MD | University of Colorado | None | None | None | None | Medtronic# | None |
Deborah Young-Hyman, PhD, CDCES | Behavioral Health & Social Science Research, National Institutes of Health | None | None | None | None | None | None |
American College of Cardiology Designated Representatives (Section 10 “Cardiovascular Disease and Risk Management”) | |||||||
Sandeep Das, MD, MPH, FACC | University of Texas Southwestern Medical Center | None | None | Associate Editor | None | None | None |
Mikhail Kosiborod, MD, FACC | Saint Luke’s Mid America Heart Institute | AstraZeneca#, Boehringer-Ingelheim# | AstraZeneca# | None | None | Amgen*, Applied Therapeutics#, AstraZeneca*#, Bayer*, Boehringer Ingelheim*, Eli Lilly, Janssen#, Merck Diabetes*, Novo Nordisk*#, Sanofi*, Vifor Pharma*# | None |
American Diabetes Association Staff | |||||||
Mindy Saraco, MHA | American Diabetes Association | None | None | None | None | None | None |
Malaika I. Hill, MA | American Diabetes Association | None | None | None | None | None | None |
Matthew P. Petersen | American Diabetes Association | None | None | None | None | None | None |
Shamera Robinson, MPH, RDN | American Diabetes Association | None | None | None | None | None | None |
Jo Mandelson, MS, RDN | American Diabetes Association | None | None | None | None | None | None |
Robert A. Gabbay, MD, PhD | American Diabetes Association (Joslin Diabetes Center) | None | None | None | None | Onduo*, Health Reveal, Form Health, Lark*, Vida Health* | Spouse Christi Gabbay, CHSE, Managing Director, Major Gifts and Philanthropy at American Diabetes Association |
Kenneth P. Moritsugu, MD, MPH | American Diabetes Association, First Samurai Consulting, LLC | None | None | None | First Samurai Consulting, LLC | None | None |
BOD, board of directors; IOM, Institute of Medicine; NASH, nonalcoholic steatohepatitis.
*
≥$10,000 per year from company to individual.
#
Grant or contract is to university or other employer. Kenneth P. Moritsugu, MD, MPH, worked as the Interim Chief Scientific and Medical Officer of the American Diabetes Association (ADA) until July 2020. Prior to joining ADA in July 2020, Robert Gabbay, MD, PhD, was employed by Joslin Diabetes Center.
© 2020 by the American Diabetes Association
2020
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.